Jason Hoitt Insider Profile
4 Followers
Jason Hoitt, CCO at Dova Pharmaceuticals, holds 10.28K shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in Provention Bio (Ticker: PRVB), holds 0.00 shares in Dova Pharmaceuticals (Ticker: DOVA). Most recently, Jason Hoitt Sold ― shares of Stoke Therapeutics on Mar 19, 2026 for an estimated value of $119.29K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+49.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Patient Officer
Roles that Jason Hoitt holds in companies
Most Profitable Insider Trade
Stock:
Provention Bio
(PRVB)
(PRVB)
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+102.40%
The most profitable trade made by Jason Hoitt
Jason Hoitt's Trading History
Dova Pharmaceuticals
Nov 12, 2019
―
Uninformative Sell
―
$0.00
Provention Bio
Feb 14, 2023
―
Uninformative Sell
45.00K
$0.00
Stoke Therapeutics
Mar 19, 2026
Chief Patient Officer
Informative Sell
119.29K
$336.23K
List of latest transactions for each holding click on a transaction to see Jason Hoitt's performance on stock
You May Also Like
Jason Hoitt insider profile FAQ
What is the percentage of profitable transactions made by Jason Hoitt?
The percentage of profitable transactions made by Jason Hoitt is 50%.
What is the average return per transaction made by Jason Hoitt?
The average return per transaction made by Jason Hoitt is 49.90%.
What stocks does Jason Hoitt hold?
Jason Hoitt holds: DOVA, PRVB, STOK stocks.
What was Jason Hoitt’s latest transaction?
Jason Hoitt latest transaction was an Informative Sell of $119.29K.
What was Jason Hoitt's most profitable transaction?
Jason Hoitt’s most profitable transaction was an Informative Buy of PRVB stock on March 20, 2020. The return on the trade was 102.40%.
What is Jason Hoitt's role in Dova Pharmaceuticals?
Jason Hoitt's role in Dova Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.